NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading provider of clinical trial solutions, today announced that Quintiles Transnational Corp., a worldwide leader in pharmaceutical services, has achieved Medidata’s highest accreditation status, Rave Accredited Plus, within Medidata’s ASPire to Win® partner program. The accreditation marks a significant milestone in the relationship, which has enabled Quintiles to leverage Medidata Rave® electronic data capture (EDC), management and reporting software for its clients.
